Keywords: eu, applications, amphocil, complete, liposome, technology, zeneca

EU APPLICATIONS FOR AMPHOCIL COMPLETE

Article | 13 June 1994

Liposome Technology and Zeneca Pharmaceuticals have submitted marketing authorization applications for the liposomal amphotericin B antifungal Amphocil in Finland, Sweden ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Abelcet

Amphotericin B

Ambisome

Fungizone

Go to drug listing